Skip to main content
Elsevier

Decellularization Technology in Regenerative Medicine and Tissue Bioengineering

  • 1st Edition - October 1, 2026
  • Latest edition
  • Editors: Ekaterine Berishvili, Antonio Citro, Andrea Peloso
  • Language: English

Decellularization Technology in Regenerative Medicine and Tissue Bioengineering is the fifth volume in the Regenerative and Transplant Medicine Series. Organ transplantation remain… Read more

Data Mining & ML

Unlock the cutting edge

Up to 20% on trusted resources. Build expertise with data mining, ML methods.

Explore now

Description

Decellularization Technology in Regenerative Medicine and Tissue Bioengineering is the fifth volume in the Regenerative and Transplant Medicine Series. Organ transplantation remains the gold standard for treating various end-stage tissue and organ failures. Regenerative medicine aims to address this gap by using cells, biomaterials, and bioactive molecules to restore or replace damaged tissues and organs. Decellularization technology stands at the forefront of these efforts, offering numerous advantages over traditional transplantation methods. This volume aims to capture the recent progress and future directions in decellularization technology, addressing the current challenges and exploring the potential clinical applications. It brings together contributions from leading experts in the field, providing a valuable resource for researchers, clinicians, and students involved in regenerative medicine and tissue engineering.

Key features

  • Provides a comprehensive overview of decellularization protocols of different organs
  • Presents detailed methodologies and protocols, enabling users to replicate and optimize techniques
  • Includes diagrams and illustrations, enhancing comprehension of complex concepts

Readership

Organ Transplant Surgeons, Regenerative Medicine Researchers, Tissue Engineering Operators, Biotech Operators, Academia, Industry and Regulatory Agencies and Operators

Table of contents

1. Introduction to Decellularization Technology

2. Optimization of Decellularization Techniques for Various Tissues and Organs

3. Bioscaffold Recellularization

4. Applications of Decellularized Tissues and Organs

5. Extracellular Matrix Hydrogels from Decellularized Tissues

6. Decellularized Extracellular Matrix as Ink for 3D Bioprinting

7. Stem Cell Differentiation Using Decellularized Matrix

8. Decellularized ECM for Cancer Bioengineering

9. Current Challenges and Future Perspectives in Decellularization Technology

Product details

  • Edition: 1
  • Latest edition
  • Published: October 1, 2026
  • Language: English

About the editors

EB

Ekaterine Berishvili

Ekaterine Berishvili obtained her MD and PhD degrees in Tbilisi, Georgia, in 1999 and 2003. Between 2003 and 2014, she held research fellow and visiting professor positions at the Diabetes Research Institute, University of Miami (Prof. Camillo Ricordi) and at the Albert Einstein College of Medicine, New York (Prof. Sanjeev Gupta). She was promoted associate professor at Tbilisi State Medical University (2008-2014) and is currently holding an associate professorship at Ilia State University, in Tbilisi. She has been working as a scientific collaborator in the department of surgery at the University of Geneva since 2014, and was appointed in 2020 as a leader of research group of Tissue Engineering and Organ Regeneration in the Department of Surgery.
Affiliations and expertise
Associate Professor, University of Geneva, Geneva, Switzerland

AC

Antonio Citro

Dr. Antonio Citro received his doctor degree in Medical Biotechnology in 2009 and he obtained a Ph.D. in Experimental surgery and Microsurgery in 2014, both at University of Pavia.

Since 2016, Antonio focused his research on regenerative medicine and imported to San Raffaele the knowledge of multiple organ engineering and bioreactor customization that he learned at Harvard Stem Cell Institute, Boston.

Since November 2019, he has been Project Leader at IRCCS Ospedale San Raffaele at the Diabetes Research Institute. Dr. Citro has received several honours, including the Premio Umberto di Mario from Italian Diabetes Society (SID), best oral communication at the 2021 IPITA meeting and different EPITA Awards from the European Society for Organ Transplantation. He contributes to the JDRF beta cell replacement consortium and serves on the editorial board of Transplant International and Frontiers Bioengineering and Biotechnology - section Regenerative medicine and Tissue Engineering.

Affiliations and expertise
Project Leader, IRCCS Ospedale San Raffaele, Milan, Italy

AP

Andrea Peloso

Dr Andrea Peloso graduated from the University of Pavia in Italy. From the start, he had a vision of a dual clinical and research career, and pursued a PhD in Experimental surgery and Microsurgery, before a post-doctoral 18-month research at the Wake Forest Institute for Regenerative Medicine, focusing his research on regenerative medicine and organ bioengineering applied to general surgery and solid organ transplantation.

After his training he moved to the University of Geneva, Switzerland, where he now has an academic appointment as Privat Docent. Since 2017, he’s been training as an abdominal surgeon and then as a more specialized surgeon dedicated to the management of liver and pancreas diseases through surgery of transplantation.

Dr. Peloso has published more than 100 papers. He has received several awards both locally and internationally and has been supported by various institutions including Juvenile Diabetes Research Foundation and the Swiss National Science Foundation.

Affiliations and expertise
Chief Scientific Officer, University of Geneva Medical School, Geneva, Switzerland